Since olfactory epithelial cells in COVID-19 patients have high levels of NRP-1 and VEGF-A is a ligand for NRP-1, this implies that one explanation for the patient's cognitive and neurological impairments could be the sensitivity of these brain regions to SARS-CoV-2 [118]. The gene discussed is NRP1; the disease is COVID-19.